Rhythm Pharmaceuticals
RYTM
48,93 €
Share price
-3.34%
Change (1 day)
23.74%
Change (1 year)
Categories
Earnings for Rhythm Pharmaceuticals (RYTM)
Earnings in 2024 (TTM): -€0.25 Billion
According to Rhythm Pharmaceuticals's latest financial reports the company's current earnings are €0.13 Billion. a decrease over its 2023 earnings that were of -€0.18 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Rhythm Pharmaceuticals from 2017 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -€0.25 Billion | 41.34% |
| 2023 | -€0.18 Billion | 1.65% |
| 2022 | -€0.17 Billion | 160.18% |
| 2021 | -€64.31 Million | -48.05% |
| 2020 | -€0.13 Billion | -4.78% |
| 2019 | -€0.14 Billion | 90.01% |
| 2018 | -€68.43 Million | 119.72% |
| 2017 | -€31.15 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -€0.14 Billion | -45.09% | 🇺🇸 USA |